Zisková marže společnosti 4SC AG
Jaká je hodnota metriky Zisková marže společnosti 4SC AG?
Hodnota metriky Zisková marže společnosti 4SC AG je -843.16%
Jaká je definice metriky Zisková marže?
Zisková marže (Profit margin) je procento čistého zisku z celkových tržeb.
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
Zisková marže společností v sektoru Health Care sektor na XETRA ve srovnání se společností 4SC AG
Čemu se věnuje společnost 4SC AG?
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
Firmy s metrikou zisková marže podobnou společnosti 4SC AG
- Hodnota metriky Zisková marže společnosti Tai United je -853.21%
- Hodnota metriky Zisková marže společnosti First Graphene je -851.85%
- Hodnota metriky Zisková marže společnosti First Graphene je -851.85%
- Hodnota metriky Zisková marže společnosti Novonix je -848.69%
- Hodnota metriky Zisková marže společnosti OncoSil Medical je -847.95%
- Hodnota metriky Zisková marže společnosti Gritstone Bio Inc je -847.34%
- Hodnota metriky Zisková marže společnosti 4SC AG je -843.16%
- Hodnota metriky Zisková marže společnosti Outlook Therapeutics Inc je -840.70%
- Hodnota metriky Zisková marže společnosti Relief Therapeutics AG je -835.36%
- Hodnota metriky Zisková marže společnosti Kalamazoo Resources je -832.34%
- Hodnota metriky Zisková marže společnosti ITM Power Plc je -829.82%
- Hodnota metriky Zisková marže společnosti Atlanta je -829.74%
- Hodnota metriky Zisková marže společnosti Fatfish Blockchain je -828.33%